| Names | |
|---|---|
| IUPAC name [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C15H22N2O6 | |
| Molar mass | 326.349 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Nipradilol is a beta blocker and nitric oxide donor. [1]
| Forms | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Targets |
| ||||||||||||||
| NO donors (prodrugs) |
| ||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||
| Others |
| ||||||||||||||
See also: Receptor/signaling modulators | |||||||||||||||
| | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
